Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors

Bioorg Chem. 2019 Dec:93:103335. doi: 10.1016/j.bioorg.2019.103335. Epub 2019 Oct 3.

Abstract

The present study documents the synthesis of oxygenated chalcone (O1-O26) derivatives and their abilities to inhibit monoamine oxidases. All 26 derivatives examined showed potent inhibitory activity against MAO-B. Compound O23 showed the greatest inhibitory activity against MAO-B with an IC50 value of 0.0021 µM, followed by compounds O10 and O17 (IC50 = 0.0030 and 0.0034 µM, respectively). In addition, most of the derivatives potently inhibited MAO-A and O6 was the most potent inhibitor with an IC50 value of 0.029 µM, followed by O3, O4, O9, and O2 (IC50 = 0.035, 0.053, 0.072, and 0.082 µM, respectively). O23 had a high selectivity index (SI) value for MAO-B of 138.1, and O20 (IC50 value for MAO-B = 0.010 µM) had an extremely high SI of >4000. In dialysis experiments, inhibitions of MAO-A and MAO-B by O6 and O23, respectively, were recovered to their respective reversible reference levels, demonstrating both are reversible inhibitors. Kinetic studies revealed that O6 and O23 competitively inhibited MAO-A and MAO-B, respectively, with respective Ki values of 0.016 ± 0.0007 and 0.00050 ± 0.00003 µM. Lead compound are also non-toxic at 200 µg/mL in normal rat spleen cells. Molecular docking simulations and subsequent Molecular Mechanics/Generalized Born Surface Area calculations provided a rationale that explained experimental data.

Keywords: Chalcone; Kinetics; MAO inhibition; Molecular docking; Reversibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chalcones / chemistry*
  • Drug Design*
  • Kinetics
  • Molecular Docking Simulation
  • Monoamine Oxidase / drug effects*
  • Monoamine Oxidase Inhibitors / chemical synthesis
  • Monoamine Oxidase Inhibitors / chemistry*
  • Monoamine Oxidase Inhibitors / pharmacology*
  • Oxygen / chemistry*
  • Rats
  • Spleen / cytology
  • Spleen / drug effects
  • Structure-Activity Relationship

Substances

  • Chalcones
  • Monoamine Oxidase Inhibitors
  • Monoamine Oxidase
  • Oxygen